Pathstone Holdings’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
16,353
+3,610
+28% +$176K ﹤0.01% 1575
2026
Q1
$547K Sell
12,743
-309
-2% -$13.3K ﹤0.01% 1717
2025
Q4
$572K Sell
13,052
-502
-4% -$20.8K ﹤0.01% 1694
2025
Q3
$560K Sell
13,554
-77
-0.6% -$3.1K ﹤0.01% 1715
2025
Q2
$601K Buy
13,631
+1,708
+14% +$68.3K ﹤0.01% 1634
2025
Q1
$440K Sell
11,923
-1,870
-14% -$66.6K ﹤0.01% 1774
2024
Q4
$459K Buy
13,793
+1,293
+10% +$41.9K ﹤0.01% 1763
2024
Q3
$324K Buy
12,500
+484
+4% +$12K ﹤0.01% 1938
2024
Q2
$270K Buy
12,016
+2,062
+21% +$45.7K ﹤0.01% 1992
2024
Q1
$236K Buy
9,954
+1,173
+13% +$26.1K ﹤0.01% 2060
2023
Q4
$211K Buy
+8,781
New +$191K ﹤0.01% 2034

Other funds holding EXEL

Pathstone Holdings's EXEL Position: Q2 2026 in Review

Pathstone Holdings increased its Exelixis (EXEL) stake by 28% in Q2 2026, buying an estimated $176K and bringing the position to 16,353 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Pathstone Holdings first reported a position in EXEL in Q4 2023 and has held it in 11 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Pathstone Holdings held 16,353 shares of Exelixis worth $890K as of Q2 2026.
  • Pathstone Holdings bought 3,610 Exelixis shares in Q2 2026, an estimated $176K.
  • Exelixis made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1575 holding.
  • Pathstone Holdings first reported a position in Exelixis in Q4 2023 and has held it in 11 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.